Table 2.
Baseline clinical characteristics of the PD cohort (n=87) used in this study.
| Clinical characteristic | Mean (SD) or n (%) |
|---|---|
| Gender | |
| Male | 54 (62%) |
| Female | 33 (38%) |
| Age (years) | 62.8 (9.2) |
| Age of onset (years) | 53.3 (10.2) |
| Disease duration (years) | 10.4 (6.8) |
| Dopamine agonist usage | |
| Yes | 45 (51.7%) |
| No | 42 (48.3%) |
| LEDD (mg) | 671 (389) |
| Deep brain stimulation | |
| Yes | 14 (16.1%) |
| No | 73 (83.9%) |
| Smoking history | |
| Yes | 13 (14.9%) |
| No | 74 (85.1%) |
| Level of education | |
| Secondary school | 58 (66.7%) |
| Tertiary education | 29 (33.3%) |
| MDS-UPDRS III (motor) | 18 (14.2) |
| Cognitive status | |
| Cognitively impaired | 22 (25.3%) |
| Not cognitively impaired | 65 (74.7%) |
| BIS-11 scores | |
| Attentional 2nd order | 15.8 (3.7) |
| Nonplanning 2nd order | 24.8 (4.9) |
| Total score | 62.5 (8.9) |